Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Cancer Surgery Trials

Virginia

Cancer surgery and procedure trials in Virginia

77 cancer surgery and procedure studies are recruiting participants at sites in 25 cities across Virginia as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 350-9284
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Virginia city with a recruiting study

By research area: Lymphoma (30), Lung Cancer (14), Breast Cancer (13), Prostate Cancer (9), Melanoma (6), Pancreatic Cancer (5).

Richmond (60), Charlottesville (32), Midlothian (13), South Hill (13), Mechanicsville (12), Falls Church (11), Norfolk (11), Roanoke (10), Fairfax (8), Lynchburg (7), Tappahannock (6), Fishersville (5), McLean (5), Woodbridge (5), Alexandria (4), Bristol (4), Fredericksburg (3), Leesburg (3), Portsmouth (3), Winchester (3), Chesapeake (2), Norton (2), Harrisonburg (1), Newport News (1), Virginia Beach (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Virginia

Basic details from each study's public record (the 12 most recently updated of 77). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Richmond
    Registry record
    NCT03606967 · updated
  2. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    • Phase 2
    • All ages
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Bristol · Charlottesville · Fairfax · and 4 more U.S. locations
    Registry record
    NCT05564377 · updated
  3. The Vanguard Study: Testing a New Way to Screen for Cancer

    • No phase
    • Ages 45 to 75
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Charlottesville · Fairfax · Harrisonburg · and 4 more U.S. locations
    Registry record
    NCT06995898 · updated
  4. Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Fishersville · Lynchburg · Mechanicsville · and 2 more U.S. locations
    Registry record
    NCT07391774 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Virginia on ClinicalTrials.gov.

Lung cancer: recently updated in Virginia

  1. Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Fredericksburg · Lynchburg · Richmond · and 1 more U.S. location
    Registry record
    NCT06498635 · updated
  2. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Charlottesville · Richmond
    Registry record
    NCT06287775 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Virginia on ClinicalTrials.gov.

Melanoma: recently updated in Virginia

  1. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Alexandria · Fairfax · Falls Church · and 3 more U.S. locations
    Registry record
    NCT05136196 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Virginia on ClinicalTrials.gov.

Lymphoma: recently updated in Virginia

  1. Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Richmond
    Registry record
    NCT03739814 · updated
  2. Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Richmond
    Registry record
    NCT04301076 · updated
  3. Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

    • Phase 2
    • Up to 365 days
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Charlottesville · Norfolk · Richmond · and 1 more U.S. location
    Registry record
    NCT06317662 · updated
  4. Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Charlottesville · Richmond
    Registry record
    NCT06337318 · updated
  5. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Recruiting in
    Charlottesville · Falls Church · Norfolk · and 2 more U.S. locations
    Registry record
    NCT04726241 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Virginia on ClinicalTrials.gov.

Ask about studies in Virginia

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a surgery or another procedure, as each study is coded in the registry.

Cancer Surgery Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 350-9284

or send a short form

How should we reach you?

Call